FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
ENMD-1198, 864668-87-1, ENMD-1198 Intermediate 362-08-3, stock 414.4g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |
ENMD-1198, 864668-87-1, ENMD-1198 Intermediate 438044-29-2, stock 394.5g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply. |
ENMD-1198, 864668-87-1, ENMD-1198 Intermediate 864668-81-5, stock 108.2g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |
ENMD-1198, 864668-87-1, ENMD-1198 Intermediate 864668-84-8, stock 502.4g, white powder, assay by HPLC 100%, HNMR, LCMS we supply. |
ENMD-1198, 864668-87-1, ENMD-1198 Intermediate 864668-87-1, stock 728.3g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |